SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

ViaDerma Inc. (VDRM)

VDRM RSS Feed
Add VDRM Price Alert      Hide Sticky   Hide Intro
Moderator: mick, balamidas, Helter Skelter, GoldenDD, stockdarockk, CMIH
Search This Board:
Last Post: 12/4/2016 8:47:23 PM - Followers: 163 - Board type: Free - Posts Today: 20

VDRM

ViaDerma, Inc.

A Division of ViaDerma, Inc. , A Public Company.

Breakthrough Rapid Delivery of Nutrients and Medicines

ViaDerma, Inc. is a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to stem-cell therapy.

About Our Products

 

Proprietary and Trade Secret Mechanism of Action

ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.

The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.

This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.

The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.

Skin Layer Organization

A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.

The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.

Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.

In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.

APPLICATIONS & USAGE

We are developing products in the following fields of use;

Topical antibiotics

Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.

  • Estimated Global prevalence rate of all types of bacterial infection including pets: 2 Billion.
    Estimated Global prevalence rate of MRSA: 140 million.
Topical toenail antifungal

Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.

Anti-viral formula

Treats symptoms of Influenza which is a$4B/ year global market: Common

  • Estimated Global prevalence rate of Influenza: 355-1065 million.
    Estimated Global prevalence rate of “Bird Flu”: Very rare, about 500 cases.
    Estimated Global prevalence rate of “Swine Flu”: 1420 million were infected in 2009
Wound care

Diabetic foot wounds.

  • Diabetic foot Ulcers; $1.5B/year global market. 12 million people per year

Contact Details

ViaDerma's global headquarters is located at
8950 W. Olympic Blvd, Suite 576, Beverly Hills, CA 90211.

We are currently in discussions with companies in Australia & New Zealand, India, China, and West Africa.

Phone: 310.871.3996

Headlines Get Headlines for:

Tuesday, August 5, 2014

Tuesday, June 10, 2014

Older Headlines - Most Recent Headlines

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

Authorized Shares: 400,000,000 a/o Nov 10, 2016

Outstanding Shares: 200,319,103 a/o Nov 10, 2016

Float: 51,061,509 a/o June 30, 2016

Low Floaters Move Fast!

Par Value    0.001

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

$VDRM COULD BE THE pharmacy stock of the year. This stock could run 30,000% here's why.

1) EXTREMELY OVERSOLD and unknown 
2) ONLY 150 MILLION A\S! Makes it the TINIEST FLOAT VS PRICE out of ALL pharmacy stockso in the whole country!
3) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER. 
4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.
5) INSIDERS OWN 75 MILLION SHARES, that's right 75 MILLION!
6) WON AWARD FOR THEIR DRUG
7) STRONG HANDS HOLDING 11 million shares out of the TINY 18 million float.
8) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.
9) THEY HAVE A PATENT which big boys have to be eyeing.

VDRM IS A HIDDEN GOLDMINE

THIS IS NOT A REGULAR PENNY STOCK. The LOWEST FLOAT vs price vs ALL PHARMA STOCKS IN THE COUNTRY. BIG BOARD OR OTC LAND. ALL OF THEM. Pharma stocks have the HIGHIGHEST EST percentage gain in big boards or penny stocks

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HUGE:
 

VDRM ENTERS MMJ PLAYING FIELD

LOS ANGELES, CA--(Marketwired - November 14, 2016) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, announced today the Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases. The transdermal system can deliver through topical skin absorption to localized areas and directly into the blood stream. The Patent application using the combination of CBD's and THC with the delivery system was filed in 2014. The Patent Pending transdermal system can deliver medications and nutrients into the body through the skin. For example, a person with a migraine headache can place the CBD and THC combined with the delivery compound and apply to the neck with immediate absorption into the bloodstream through the corroded artery. ViaDerma, Inc. is also in the clinical testing stages of an anti-aging topical solution, topical pain medication, a topical for male-pattern baldness, and a topical designed to boost male libido.

On November 8th, medical and recreational marijuana was passed in several states that voted on medical marijuana provisions, in what is turning out to be, the biggest electoral victory for marijuana reform since 2012. The use of CBD's is known for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VDRM
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#5180  Sticky Note VDRM NEWS! >> Clinical Tests Show Dramatic Success Helter Skelter 12/01/16 12:51:18 AM
#5015  Sticky Note VDRM MUCH HIGHER $1.50 to $5.00 NEAR TERM 2dollarbill 11/26/16 07:11:25 PM
#3497  Sticky Note ViaDerma, Inc. Enters the (MMJ) or Medical balamidas 11/15/16 10:16:08 AM
#5413   Sell now then, there's very little chance they Kgs68 12/04/16 08:47:23 PM
#5412   Thank you. HOLDING trackkwizzard 12/04/16 08:08:41 PM
#5411   $VDRM added more on Friday. The next huge BCNstocks 12/04/16 07:53:04 PM
#5410   Revenues climbed 47 times or 4757% Avoid 12/04/16 07:46:30 PM
#5409   Viaderma Inc is a pharmaceutical company focused on bringing Avoid 12/04/16 07:43:13 PM
#5408   The company is also seeking to venture in Avoid 12/04/16 07:41:56 PM
#5407   “We are also in the clinical testing stages Avoid 12/04/16 07:41:11 PM
#5406   In a press release this week, Viaderma Inc Avoid 12/04/16 07:40:10 PM
#5405   The transfer agent is NOT gagged. Call. Him, jaconow 12/04/16 05:33:34 PM
#5404   Because they really are invested and is taking beargroup 12/04/16 12:09:24 PM
#5403   If I was you I'd be more worried Kgs68 12/04/16 10:49:51 AM
#5402   The irony of all these posts of yours Kgs68 12/04/16 10:40:10 AM
#5398   VDRM IS NOT EVEN MJ.JUST HYPED ON FLUFF MG-Trader 12/04/16 02:10:45 AM
#5397  Restored MORE DUMP COMING.......BUYERS BEWARE..... MG-Trader 12/04/16 02:09:57 AM
#5395   POS DUMPING HARD ON FLUFF NEWS TRIPS COMMETH..... MG-Trader 12/04/16 02:06:33 AM
#5392   "As of September 30, 2016, the Company had Avoid 12/03/16 06:24:34 PM
#5391   "We are attempting to negotiate payoffs on most Avoid 12/03/16 06:22:28 PM
#5390   The Company had revenues of $83,500 and $209,573 Avoid 12/03/16 06:18:54 PM
#5389   Beneficial owners. Avoid 12/03/16 05:58:39 PM
#5387   Someone wants in! Welcome Kgs68 12/03/16 03:07:12 PM
#5386   This is a royal POS . It dumps droopyeyes 12/03/16 02:38:56 PM
#5383   ad some this week long and strong steez 12/03/16 10:34:43 AM
#5380   I AGREE ABSOLUTE TOXIC JUNK. John Kent 12/03/16 08:38:18 AM
#5379   MASSIVE DILUTION HERE ONLY A MATTER OF TIME John Kent 12/03/16 08:35:08 AM
#5378   VDRM dumped 25mill shares and more dumps are John Kent 12/03/16 08:31:37 AM
#5377   Added today again. Looked @ the "history" and shanett 12/02/16 06:55:05 PM
#5376   I agree, not many shares added to o/s nsomniyak 12/02/16 06:50:30 PM
#5372   l O l...2 days. November 15th and 16th. Helter Skelter 12/02/16 05:16:39 PM
#5371   Sure you can when you clearly state 'average'. Helter Skelter 12/02/16 04:52:44 PM
#5370  Restored You can't divide the 25 million by 40 CMIH 12/02/16 04:25:25 PM
#5369   VDRM 13,817,570 for $41,504 on 149 trades... Helter Skelter 12/02/16 04:19:25 PM
#5368   I'll bid trips . Could be a nice,scoop weasel4339 12/02/16 03:36:53 PM
#5365   Full stochastic daily is oversold! Coming out above Long Fire 12/02/16 02:49:19 PM
#5364   Sorry but not my first day in school... willc218 12/02/16 02:48:27 PM
#5363   Will do.... DLP 12/02/16 01:58:46 PM
#5362   Thanks. So nice, if I do say so Helter Skelter 12/02/16 01:57:59 PM
#5361   Nice Helter Skelter...$VRDM...DLP DLP 12/02/16 01:52:01 PM
#5360   •<>• VDRM Share Structure •<>• Helter Skelter 12/02/16 01:23:24 PM
#5359   Yup the volume really shows that. (NOT) Obi-Jan-Kenobi 12/02/16 01:11:34 PM
#5358   Bullshit. Helter Skelter 12/02/16 01:08:46 PM
#5357   willy, it's hard to argue against what Monster industrialist 12/02/16 12:59:20 PM
#5356   toxic shares converted at .0005 PPS dumping at MonstaGains 12/02/16 12:57:39 PM
#5353   Insert coin... gawd do you think anyone actually willc218 12/02/16 12:42:52 PM
#5352   massive toxic diluted junk MonstaGains 12/02/16 12:35:18 PM
#5351   Remember... > these dramatically successful tests are with Helter Skelter 12/02/16 12:26:02 PM
#5350   I wish they did a good job of Helter Skelter 12/02/16 12:14:41 PM
#5349   Probably one of the biggest pump news headlines industrialist 12/02/16 11:57:42 AM
#5347   Very low for a subbie... something is in willc218 12/02/16 10:58:57 AM
#5346   The immediate catalyst is that VDRM is greatly Helter Skelter 12/02/16 10:58:05 AM
#5345   I like the Float. I assume that with Obi-Jan-Kenobi 12/02/16 10:47:45 AM
PostSubject